- Home
- CKPT vs HITI Comparison
CKPT vs HITI Comparison
Compare CKPT & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKPT
- HITI
- Stock Information
- Founded
- CKPT 2014
- HITI 2009
- Country
- CKPT United States
- HITI Canada
- Employees
- CKPT N/A
- HITI N/A
- Industry
- CKPT Biotechnology: Pharmaceutical Preparations
- HITI
- Sector
- CKPT Health Care
- HITI
- Exchange
- CKPT Nasdaq
- HITI Nasdaq
- Market Cap
- CKPT 214.4M
- HITI 188.0M
- IPO Year
- CKPT 2017
- HITI N/A
- Fundamental
- Price
- CKPT $3.61
- HITI $3.05
- Analyst Decision
- CKPT Strong Buy
- HITI Strong Buy
- Analyst Count
- CKPT 3
- HITI 1
- Target Price
- CKPT $10.33
- HITI $4.50
- AVG Volume (30 Days)
- CKPT 2.4M
- HITI 860.2K
- Earning Date
- CKPT 11-12-2024
- HITI 01-27-2025
- Dividend Yield
- CKPT N/A
- HITI N/A
- EPS Growth
- CKPT N/A
- HITI N/A
- EPS
- CKPT N/A
- HITI N/A
- Revenue
- CKPT $47,000.00
- HITI $370,017,302.00
- Revenue This Year
- CKPT N/A
- HITI $7.52
- Revenue Next Year
- CKPT $151,162.55
- HITI $13.35
- P/E Ratio
- CKPT N/A
- HITI N/A
- Revenue Growth
- CKPT N/A
- HITI 9.02
- 52 Week Low
- CKPT $1.38
- HITI $1.55
- 52 Week High
- CKPT $4.50
- HITI $3.62
- Technical
- Relative Strength Index (RSI)
- CKPT 41.64
- HITI 47.50
- Support Level
- CKPT $2.98
- HITI $2.87
- Resistance Level
- CKPT $4.44
- HITI $3.20
- Average True Range (ATR)
- CKPT 0.42
- HITI 0.20
- MACD
- CKPT -0.10
- HITI -0.06
- Stochastic Oscillator
- CKPT 25.66
- HITI 15.25
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker's Corner Ltd., Grasscity.com, Canna Cabana Inc., and KushBar Inc. The firm has established two main segments, retail and wholesale. It generates substantial revenue from retail stores' e-commerce platforms. Geographically it serves Canada, the USA, and other international markets and earns key revenue from domestic sales.